nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—ALB—chronic obstructive pulmonary disease	0.38	1	CbGaD
Oxcarbazepine—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0727	0.188	CbGbCtD
Oxcarbazepine—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0727	0.188	CbGbCtD
Oxcarbazepine—ALB—Prednisone—chronic obstructive pulmonary disease	0.0471	0.121	CbGbCtD
Oxcarbazepine—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0464	0.12	CbGbCtD
Oxcarbazepine—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0313	0.0808	CbGbCtD
Oxcarbazepine—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0305	0.0788	CbGbCtD
Oxcarbazepine—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0299	0.0771	CbGbCtD
Oxcarbazepine—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0266	0.0687	CbGbCtD
Oxcarbazepine—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0156	0.0403	CbGbCtD
Oxcarbazepine—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0148	0.0381	CbGbCtD
Oxcarbazepine—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0015	0.0518	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00132	0.0458	CbGpPWpGaD
Oxcarbazepine—SCN5A—Cardiac Progenitor Differentiation—TNNT2—chronic obstructive pulmonary disease	0.00129	0.0445	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00108	0.0374	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.000822	0.0284	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.000748	0.0259	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000597	0.0206	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00055	0.019	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000544	0.0188	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000532	0.0184	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000511	0.0177	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000491	0.017	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000422	0.0146	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000395	0.0137	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00038	0.0131	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.00038	0.0131	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000371	0.0128	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000357	0.0123	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000327	0.0113	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.000309	0.0107	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000293	0.0101	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000287	0.00992	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000284	0.00981	CbGpPWpGaD
Oxcarbazepine—Magnesium salicylate—ALB—chronic obstructive pulmonary disease	0.000282	0.0507	CrCbGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000276	0.00955	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000276	0.00954	CbGpPWpGaD
Oxcarbazepine—Warfarin—CYP1A1—chronic obstructive pulmonary disease	0.000272	0.0489	CrCbGaD
Oxcarbazepine—Piroxicam—ALB—chronic obstructive pulmonary disease	0.00027	0.0486	CrCbGaD
Oxcarbazepine—Epinastine—HTR2A—chronic obstructive pulmonary disease	0.000263	0.0473	CrCbGaD
Oxcarbazepine—Warfarin—CYP1A2—chronic obstructive pulmonary disease	0.000262	0.0471	CrCbGaD
Oxcarbazepine—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.00893	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.000255	0.00881	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000249	0.00862	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000247	0.00855	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000245	0.00848	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000238	0.00821	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000228	0.00789	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000228	0.00786	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000217	0.0075	CbGpPWpGaD
Oxcarbazepine—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.00109	CcSEcCtD
Oxcarbazepine—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00109	CcSEcCtD
Oxcarbazepine—Modafinil—CYP1A2—chronic obstructive pulmonary disease	0.000215	0.0386	CrCbGaD
Oxcarbazepine—Infection—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00108	CcSEcCtD
Oxcarbazepine—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00108	CcSEcCtD
Oxcarbazepine—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000213	0.00737	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000212	0.00733	CbGpPWpGaD
Oxcarbazepine—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00107	CcSEcCtD
Oxcarbazepine—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00107	CcSEcCtD
Oxcarbazepine—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00107	CcSEcCtD
Oxcarbazepine—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000212	0.00107	CcSEcCtD
Oxcarbazepine—Pulmonary oedema—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00107	CcSEcCtD
Oxcarbazepine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000211	0.00107	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000211	0.00107	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000211	0.00107	CcSEcCtD
Oxcarbazepine—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000211	0.00106	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00106	CcSEcCtD
Oxcarbazepine—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00106	CcSEcCtD
Oxcarbazepine—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00106	CcSEcCtD
Oxcarbazepine—CYP3A5—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000209	0.00724	CbGpPWpGaD
Oxcarbazepine—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00106	CcSEcCtD
Oxcarbazepine—Infection—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00106	CcSEcCtD
Oxcarbazepine—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00106	CcSEcCtD
Oxcarbazepine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000209	0.00106	CcSEcCtD
Oxcarbazepine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000209	0.00106	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000208	0.00105	CcSEcCtD
Oxcarbazepine—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.000207	0.00717	CbGpPWpGaD
Oxcarbazepine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00105	CcSEcCtD
Oxcarbazepine—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000207	0.00105	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000207	0.00104	CcSEcCtD
Oxcarbazepine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000206	0.00713	CbGpPWpGaD
Oxcarbazepine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000206	0.00104	CcSEcCtD
Oxcarbazepine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000205	0.00103	CcSEcCtD
Oxcarbazepine—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00103	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00103	CcSEcCtD
Oxcarbazepine—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00102	CcSEcCtD
Oxcarbazepine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000201	0.00102	CcSEcCtD
Oxcarbazepine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.00102	CcSEcCtD
Oxcarbazepine—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.00101	CcSEcCtD
Oxcarbazepine—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.0002	0.00101	CcSEcCtD
Oxcarbazepine—Shock—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00101	CcSEcCtD
Oxcarbazepine—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.0002	0.00101	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000199	0.00101	CcSEcCtD
Oxcarbazepine—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.001	CcSEcCtD
Oxcarbazepine—Mianserin—SLC6A4—chronic obstructive pulmonary disease	0.000198	0.0356	CrCbGaD
Oxcarbazepine—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000198	0.00684	CbGpPWpGaD
Oxcarbazepine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000197	0.000997	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000196	0.000992	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.000992	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00099	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00099	CcSEcCtD
Oxcarbazepine—Carbamazepine—CYP1A2—chronic obstructive pulmonary disease	0.000196	0.0352	CrCbGaD
Oxcarbazepine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000195	0.000983	CcSEcCtD
Oxcarbazepine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000195	0.000983	CcSEcCtD
Oxcarbazepine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.000978	CcSEcCtD
Oxcarbazepine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000193	0.000977	CcSEcCtD
Oxcarbazepine—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000193	0.000973	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000192	0.00097	CcSEcCtD
Oxcarbazepine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000192	0.000969	CcSEcCtD
Oxcarbazepine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.000969	CcSEcCtD
Oxcarbazepine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000191	0.000966	CcSEcCtD
Oxcarbazepine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.000966	CcSEcCtD
Oxcarbazepine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000191	0.000963	CcSEcCtD
Oxcarbazepine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.000959	CcSEcCtD
Oxcarbazepine—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00019	0.00656	CbGpPWpGaD
Oxcarbazepine—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000189	0.000957	CcSEcCtD
Oxcarbazepine—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000189	0.000957	CcSEcCtD
Oxcarbazepine—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000189	0.00652	CbGpPWpGaD
Oxcarbazepine—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000189	0.000953	CcSEcCtD
Oxcarbazepine—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00649	CbGpPWpGaD
Oxcarbazepine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000187	0.000946	CcSEcCtD
Oxcarbazepine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000187	0.000944	CcSEcCtD
Oxcarbazepine—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.000942	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.000938	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000186	0.000938	CcSEcCtD
Oxcarbazepine—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000185	0.000937	CcSEcCtD
Oxcarbazepine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000185	0.000937	CcSEcCtD
Oxcarbazepine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000185	0.000937	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.000935	CcSEcCtD
Oxcarbazepine—Pain—Formoterol—chronic obstructive pulmonary disease	0.000184	0.000929	CcSEcCtD
Oxcarbazepine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.000929	CcSEcCtD
Oxcarbazepine—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.000929	CcSEcCtD
Oxcarbazepine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000184	0.000929	CcSEcCtD
Oxcarbazepine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000184	0.000928	CcSEcCtD
Oxcarbazepine—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000926	CcSEcCtD
Oxcarbazepine—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000926	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000182	0.000919	CcSEcCtD
Oxcarbazepine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000182	0.000918	CcSEcCtD
Oxcarbazepine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.000915	CcSEcCtD
Oxcarbazepine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.000912	CcSEcCtD
Oxcarbazepine—Mianserin—CYP1A2—chronic obstructive pulmonary disease	0.00018	0.0325	CrCbGaD
Oxcarbazepine—Pain—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00091	CcSEcCtD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.00018	0.00621	CbGpPWpGaD
Oxcarbazepine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00018	0.000908	CcSEcCtD
Oxcarbazepine—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000179	0.000903	CcSEcCtD
Oxcarbazepine—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000179	0.000903	CcSEcCtD
Oxcarbazepine—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000178	0.0009	CcSEcCtD
Oxcarbazepine—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000178	0.0009	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000177	0.000896	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.000896	CcSEcCtD
Oxcarbazepine—Nortriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000177	0.0319	CrCbGaD
Oxcarbazepine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000177	0.000895	CcSEcCtD
Oxcarbazepine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000177	0.000892	CcSEcCtD
Oxcarbazepine—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000892	CcSEcCtD
Oxcarbazepine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000176	0.000891	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000176	0.000889	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000176	0.000889	CcSEcCtD
Oxcarbazepine—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000888	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.000886	CcSEcCtD
Oxcarbazepine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000175	0.000885	CcSEcCtD
Oxcarbazepine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000878	CcSEcCtD
Oxcarbazepine—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.000878	CcSEcCtD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000173	0.00597	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000173	0.00596	CbGpPWpGaD
Oxcarbazepine—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000172	0.000871	CcSEcCtD
Oxcarbazepine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000172	0.00594	CbGpPWpGaD
Oxcarbazepine—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000171	0.000863	CcSEcCtD
Oxcarbazepine—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.000863	CcSEcCtD
Oxcarbazepine—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00017	0.000859	CcSEcCtD
Oxcarbazepine—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.000859	CcSEcCtD
Oxcarbazepine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00017	0.000859	CcSEcCtD
Oxcarbazepine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00017	0.000859	CcSEcCtD
Oxcarbazepine—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000857	CcSEcCtD
Oxcarbazepine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000169	0.000856	CcSEcCtD
Oxcarbazepine—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00085	CcSEcCtD
Oxcarbazepine—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.000849	CcSEcCtD
Oxcarbazepine—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.000848	CcSEcCtD
Oxcarbazepine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000168	0.000848	CcSEcCtD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000168	0.0058	CbGpPWpGaD
Oxcarbazepine—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000846	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.000846	CcSEcCtD
Oxcarbazepine—SCN5A—Cardiac Progenitor Differentiation—TGFB1—chronic obstructive pulmonary disease	0.000167	0.00578	CbGpPWpGaD
Oxcarbazepine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000167	0.000844	CcSEcCtD
Oxcarbazepine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.000843	CcSEcCtD
Oxcarbazepine—Trimipramine—SLC6A4—chronic obstructive pulmonary disease	0.000167	0.03	CrCbGaD
Oxcarbazepine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000842	CcSEcCtD
Oxcarbazepine—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000167	0.000842	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000166	0.000839	CcSEcCtD
Oxcarbazepine—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000166	0.00574	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000165	0.00569	CbGpPWpGaD
Oxcarbazepine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000831	CcSEcCtD
Oxcarbazepine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000164	0.00567	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000164	0.00566	CbGpPWpGaD
Oxcarbazepine—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000163	0.000824	CcSEcCtD
Oxcarbazepine—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000162	0.00559	CbGpPWpGaD
Oxcarbazepine—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000815	CcSEcCtD
Oxcarbazepine—Nortriptyline—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.029	CrCbGaD
Oxcarbazepine—Desipramine—ADRB2—chronic obstructive pulmonary disease	0.000161	0.0289	CrCbGaD
Oxcarbazepine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000811	CcSEcCtD
Oxcarbazepine—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.000811	CcSEcCtD
Oxcarbazepine—Doxepin—SLC6A4—chronic obstructive pulmonary disease	0.000159	0.0286	CrCbGaD
Oxcarbazepine—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.000801	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000158	0.000801	CcSEcCtD
Oxcarbazepine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000158	0.0008	CcSEcCtD
Oxcarbazepine—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000158	0.000798	CcSEcCtD
Oxcarbazepine—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000792	CcSEcCtD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000156	0.00539	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000155	0.00537	CbGpPWpGaD
Oxcarbazepine—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000155	0.000784	CcSEcCtD
Oxcarbazepine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000154	0.00078	CcSEcCtD
Oxcarbazepine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000154	0.00078	CcSEcCtD
Oxcarbazepine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000154	0.00533	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000153	0.00529	CbGpPWpGaD
Oxcarbazepine—Mianserin—HTR2A—chronic obstructive pulmonary disease	0.000152	0.0274	CrCbGaD
Oxcarbazepine—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.000769	CcSEcCtD
Oxcarbazepine—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000152	0.000769	CcSEcCtD
Oxcarbazepine—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.00526	CbGpPWpGaD
Oxcarbazepine—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000768	CcSEcCtD
Oxcarbazepine—Warfarin—ALB—chronic obstructive pulmonary disease	0.000151	0.0272	CrCbGaD
Oxcarbazepine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000151	0.000764	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000756	CcSEcCtD
Oxcarbazepine—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000149	0.000753	CcSEcCtD
Oxcarbazepine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000147	0.000744	CcSEcCtD
Oxcarbazepine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000147	0.000744	CcSEcCtD
Oxcarbazepine—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.00074	CcSEcCtD
Oxcarbazepine—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000737	CcSEcCtD
Oxcarbazepine—Desipramine—SLC6A4—chronic obstructive pulmonary disease	0.000146	0.0262	CrCbGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000146	0.00504	CbGpPWpGaD
Oxcarbazepine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000146	0.000736	CcSEcCtD
Oxcarbazepine—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000733	CcSEcCtD
Oxcarbazepine—Doxepin—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.026	CrCbGaD
Oxcarbazepine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000144	0.000728	CcSEcCtD
Oxcarbazepine—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.000726	CcSEcCtD
Oxcarbazepine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000142	0.000719	CcSEcCtD
Oxcarbazepine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.000719	CcSEcCtD
Oxcarbazepine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000139	0.000704	CcSEcCtD
Oxcarbazepine—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000139	0.000703	CcSEcCtD
Oxcarbazepine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000139	0.000702	CcSEcCtD
Oxcarbazepine—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000138	0.00477	CbGpPWpGaD
Oxcarbazepine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000137	0.000691	CcSEcCtD
Oxcarbazepine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000137	0.000691	CcSEcCtD
Oxcarbazepine—Nortriptyline—HTR2A—chronic obstructive pulmonary disease	0.000136	0.0245	CrCbGaD
Oxcarbazepine—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.000685	CcSEcCtD
Oxcarbazepine—Rash—Formoterol—chronic obstructive pulmonary disease	0.000136	0.000685	CcSEcCtD
Oxcarbazepine—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000685	CcSEcCtD
Oxcarbazepine—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000685	CcSEcCtD
Oxcarbazepine—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000685	CcSEcCtD
Oxcarbazepine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000135	0.000681	CcSEcCtD
Oxcarbazepine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000135	0.000681	CcSEcCtD
Oxcarbazepine—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00068	CcSEcCtD
Oxcarbazepine—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00068	CcSEcCtD
Oxcarbazepine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.000679	CcSEcCtD
Oxcarbazepine—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000134	0.000678	CcSEcCtD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000134	0.00463	CbGpPWpGaD
Oxcarbazepine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000134	0.000677	CcSEcCtD
Oxcarbazepine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.00459	CbGpPWpGaD
Oxcarbazepine—Rash—Montelukast—chronic obstructive pulmonary disease	0.000133	0.000671	CcSEcCtD
Oxcarbazepine—Desipramine—CYP1A2—chronic obstructive pulmonary disease	0.000133	0.0239	CrCbGaD
Oxcarbazepine—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000133	0.000671	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000669	CcSEcCtD
Oxcarbazepine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000132	0.000667	CcSEcCtD
Oxcarbazepine—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00013	0.000659	CcSEcCtD
Oxcarbazepine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000129	0.000653	CcSEcCtD
Oxcarbazepine—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000129	0.00065	CcSEcCtD
Oxcarbazepine—Promazine—CYP1A2—chronic obstructive pulmonary disease	0.000129	0.0231	CrCbGaD
Oxcarbazepine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000648	CcSEcCtD
Oxcarbazepine—Trimipramine—HTR2A—chronic obstructive pulmonary disease	0.000128	0.0231	CrCbGaD
Oxcarbazepine—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000647	CcSEcCtD
Oxcarbazepine—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000647	CcSEcCtD
Oxcarbazepine—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000646	CcSEcCtD
Oxcarbazepine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000128	0.000646	CcSEcCtD
Oxcarbazepine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.000646	CcSEcCtD
Oxcarbazepine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000643	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.000634	CcSEcCtD
Oxcarbazepine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000125	0.000632	CcSEcCtD
Oxcarbazepine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000125	0.00432	CbGpPWpGaD
Oxcarbazepine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.000625	CcSEcCtD
Oxcarbazepine—Imipramine—SLC6A4—chronic obstructive pulmonary disease	0.000124	0.0222	CrCbGaD
Oxcarbazepine—Promethazine—HTR2A—chronic obstructive pulmonary disease	0.000123	0.0222	CrCbGaD
Oxcarbazepine—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.000623	CcSEcCtD
Oxcarbazepine—Amitriptyline—SLC6A4—chronic obstructive pulmonary disease	0.000123	0.0221	CrCbGaD
Oxcarbazepine—Doxepin—HTR2A—chronic obstructive pulmonary disease	0.000122	0.022	CrCbGaD
Oxcarbazepine—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.00422	CbGpPWpGaD
Oxcarbazepine—Diazepam—CYP1A2—chronic obstructive pulmonary disease	0.000122	0.0219	CrCbGaD
Oxcarbazepine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000613	CcSEcCtD
Oxcarbazepine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.00061	CcSEcCtD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00012	0.00416	CbGpPWpGaD
Oxcarbazepine—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.000607	CcSEcCtD
Oxcarbazepine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000119	0.00412	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000118	0.00406	CbGpPWpGaD
Oxcarbazepine—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000589	CcSEcCtD
Oxcarbazepine—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.000579	CcSEcCtD
Oxcarbazepine—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000574	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000113	0.000569	CcSEcCtD
Oxcarbazepine—Imipramine—CYP1A2—chronic obstructive pulmonary disease	0.000113	0.0203	CrCbGaD
Oxcarbazepine—Desipramine—HTR2A—chronic obstructive pulmonary disease	0.000112	0.0202	CrCbGaD
Oxcarbazepine—Amitriptyline—CYP1A2—chronic obstructive pulmonary disease	0.000112	0.0201	CrCbGaD
Oxcarbazepine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000563	CcSEcCtD
Oxcarbazepine—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000559	CcSEcCtD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00011	0.0038	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.000109	0.00377	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000109	0.00376	CbGpPWpGaD
Oxcarbazepine—Promazine—HTR2A—chronic obstructive pulmonary disease	0.000109	0.0195	CrCbGaD
Oxcarbazepine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000546	CcSEcCtD
Oxcarbazepine—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000544	CcSEcCtD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000107	0.00371	CbGpPWpGaD
Oxcarbazepine—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000538	CcSEcCtD
Oxcarbazepine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000105	0.000532	CcSEcCtD
Oxcarbazepine—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000105	0.000532	CcSEcCtD
Oxcarbazepine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000527	CcSEcCtD
Oxcarbazepine—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000524	CcSEcCtD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.000103	0.00356	CbGpPWpGaD
Oxcarbazepine—SCN5A—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.000102	0.00352	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000101	0.00349	CbGpPWpGaD
Oxcarbazepine—Pain—Prednisolone—chronic obstructive pulmonary disease	9.96e-05	0.000503	CcSEcCtD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	9.86e-05	0.00341	CbGpPWpGaD
Oxcarbazepine—Vision blurred—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000494	CcSEcCtD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	9.73e-05	0.00336	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.66e-05	0.00334	CbGpPWpGaD
Oxcarbazepine—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	9.62e-05	0.000486	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	9.6e-05	0.000485	CcSEcCtD
Oxcarbazepine—Agitation—Prednisone—chronic obstructive pulmonary disease	9.53e-05	0.000482	CcSEcCtD
Oxcarbazepine—Imipramine—HTR2A—chronic obstructive pulmonary disease	9.5e-05	0.0171	CrCbGaD
Oxcarbazepine—Angioedema—Prednisone—chronic obstructive pulmonary disease	9.48e-05	0.000479	CcSEcCtD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	9.45e-05	0.00327	CbGpPWpGaD
Oxcarbazepine—Amitriptyline—HTR2A—chronic obstructive pulmonary disease	9.44e-05	0.017	CrCbGaD
Oxcarbazepine—Malaise—Prednisone—chronic obstructive pulmonary disease	9.35e-05	0.000473	CcSEcCtD
Oxcarbazepine—Vertigo—Prednisone—chronic obstructive pulmonary disease	9.32e-05	0.000471	CcSEcCtD
Oxcarbazepine—Nortriptyline—ALB—chronic obstructive pulmonary disease	9.31e-05	0.0168	CrCbGaD
Oxcarbazepine—Syncope—Prednisone—chronic obstructive pulmonary disease	9.3e-05	0.00047	CcSEcCtD
Oxcarbazepine—Urticaria—Prednisolone—chronic obstructive pulmonary disease	9.25e-05	0.000468	CcSEcCtD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.14e-05	0.00316	CbGpPWpGaD
Oxcarbazepine—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.000461	CcSEcCtD
Oxcarbazepine—SCN5A—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	9.11e-05	0.00315	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	9.07e-05	0.00313	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.01e-05	0.00311	CbGpPWpGaD
Oxcarbazepine—Convulsion—Prednisone—chronic obstructive pulmonary disease	8.99e-05	0.000454	CcSEcCtD
Oxcarbazepine—Hypertension—Prednisone—chronic obstructive pulmonary disease	8.95e-05	0.000452	CcSEcCtD
Oxcarbazepine—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	8.86e-05	0.00306	CbGpPWpGaD
Oxcarbazepine—Myalgia—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.000446	CcSEcCtD
Oxcarbazepine—Arthralgia—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.000446	CcSEcCtD
Oxcarbazepine—Anxiety—Prednisone—chronic obstructive pulmonary disease	8.8e-05	0.000445	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	8.77e-05	0.000443	CcSEcCtD
Oxcarbazepine—Discomfort—Prednisone—chronic obstructive pulmonary disease	8.72e-05	0.000441	CcSEcCtD
Oxcarbazepine—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	8.67e-05	0.00299	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	8.6e-05	0.00297	CbGpPWpGaD
Oxcarbazepine—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	8.58e-05	0.000434	CcSEcCtD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.5e-05	0.00294	CbGpPWpGaD
Oxcarbazepine—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.000428	CcSEcCtD
Oxcarbazepine—Infection—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000425	CcSEcCtD
Oxcarbazepine—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8.4e-05	0.0029	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	8.38e-05	0.0029	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	8.37e-05	0.00289	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	8.36e-05	0.00289	CbGpPWpGaD
Oxcarbazepine—Shock—Prednisone—chronic obstructive pulmonary disease	8.33e-05	0.000421	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.000419	CcSEcCtD
Oxcarbazepine—Tachycardia—Prednisone—chronic obstructive pulmonary disease	8.26e-05	0.000417	CcSEcCtD
Oxcarbazepine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	8.22e-05	0.000415	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	8.18e-05	0.000413	CcSEcCtD
Oxcarbazepine—Anorexia—Prednisone—chronic obstructive pulmonary disease	8.07e-05	0.000408	CcSEcCtD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	8e-05	0.00276	CbGpPWpGaD
Oxcarbazepine—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	7.71e-05	0.00039	CcSEcCtD
Oxcarbazepine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	7.7e-05	0.000389	CcSEcCtD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.68e-05	0.00265	CbGpPWpGaD
Oxcarbazepine—Insomnia—Prednisone—chronic obstructive pulmonary disease	7.66e-05	0.000387	CcSEcCtD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.62e-05	0.00263	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.51e-05	0.0026	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	7.51e-05	0.0026	CbGpPWpGaD
Oxcarbazepine—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	7.45e-05	0.000377	CcSEcCtD
Oxcarbazepine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	7.36e-05	0.000372	CcSEcCtD
Oxcarbazepine—Rash—Prednisolone—chronic obstructive pulmonary disease	7.34e-05	0.000371	CcSEcCtD
Oxcarbazepine—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	7.34e-05	0.000371	CcSEcCtD
Oxcarbazepine—Fatigue—Prednisone—chronic obstructive pulmonary disease	7.3e-05	0.000369	CcSEcCtD
Oxcarbazepine—Headache—Prednisolone—chronic obstructive pulmonary disease	7.3e-05	0.000369	CcSEcCtD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	7.26e-05	0.00251	CbGpPWpGaD
Oxcarbazepine—Constipation—Prednisone—chronic obstructive pulmonary disease	7.24e-05	0.000366	CcSEcCtD
Oxcarbazepine—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	7.18e-05	0.00248	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	7.17e-05	0.00248	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	7.07e-05	0.00244	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	7.06e-05	0.00244	CbGpPWpGaD
Oxcarbazepine—Diazepam—ALB—chronic obstructive pulmonary disease	7.04e-05	0.0127	CrCbGaD
Oxcarbazepine—CYP3A5—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7e-05	0.00242	CbGpPWpGaD
Oxcarbazepine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.98e-05	0.000352	CcSEcCtD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.97e-05	0.00241	CbGpPWpGaD
Oxcarbazepine—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.92e-05	0.00035	CcSEcCtD
Oxcarbazepine—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.92e-05	0.00035	CcSEcCtD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.91e-05	0.00239	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	6.84e-05	0.00236	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	6.81e-05	0.00235	CbGpPWpGaD
Oxcarbazepine—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.72e-05	0.00034	CcSEcCtD
Oxcarbazepine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	6.69e-05	0.000338	CcSEcCtD
Oxcarbazepine—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	6.69e-05	0.000338	CcSEcCtD
Oxcarbazepine—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	6.65e-05	0.0023	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.65e-05	0.0023	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.64e-05	0.00229	CbGpPWpGaD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.58e-05	0.00227	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.55e-05	0.00226	CbGpPWpGaD
Oxcarbazepine—Amitriptyline—ALB—chronic obstructive pulmonary disease	6.46e-05	0.0116	CrCbGaD
Oxcarbazepine—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	6.24e-05	0.000315	CcSEcCtD
Oxcarbazepine—Asthenia—Prednisone—chronic obstructive pulmonary disease	6.07e-05	0.000307	CcSEcCtD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	6.07e-05	0.0021	CbGpPWpGaD
Oxcarbazepine—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.99e-05	0.000303	CcSEcCtD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.97e-05	0.00206	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.89e-05	0.00204	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.81e-05	0.00201	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	5.81e-05	0.00201	CbGpPWpGaD
Oxcarbazepine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.79e-05	0.000293	CcSEcCtD
Oxcarbazepine—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	5.66e-05	0.00195	CbGpPWpGaD
Oxcarbazepine—Dizziness—Prednisone—chronic obstructive pulmonary disease	5.6e-05	0.000283	CcSEcCtD
Oxcarbazepine—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.41e-05	0.00187	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.41e-05	0.00187	CbGpPWpGaD
Oxcarbazepine—Vomiting—Prednisone—chronic obstructive pulmonary disease	5.38e-05	0.000272	CcSEcCtD
Oxcarbazepine—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	5.34e-05	0.00185	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.34e-05	0.00185	CbGpPWpGaD
Oxcarbazepine—Rash—Prednisone—chronic obstructive pulmonary disease	5.34e-05	0.00027	CcSEcCtD
Oxcarbazepine—Dermatitis—Prednisone—chronic obstructive pulmonary disease	5.33e-05	0.000269	CcSEcCtD
Oxcarbazepine—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.31e-05	0.00183	CbGpPWpGaD
Oxcarbazepine—Headache—Prednisone—chronic obstructive pulmonary disease	5.3e-05	0.000268	CcSEcCtD
Oxcarbazepine—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.13e-05	0.00177	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	5.11e-05	0.00177	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.06e-05	0.00175	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	5.05e-05	0.00175	CbGpPWpGaD
Oxcarbazepine—Nausea—Prednisone—chronic obstructive pulmonary disease	5.03e-05	0.000254	CcSEcCtD
Oxcarbazepine—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	4.94e-05	0.00171	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	4.94e-05	0.00171	CbGpPWpGaD
Oxcarbazepine—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	4.9e-05	0.00169	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	4.76e-05	0.00165	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4.71e-05	0.00163	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.6e-05	0.00159	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	4.53e-05	0.00157	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	4.35e-05	0.0015	CbGpPWpGaD
Oxcarbazepine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	4.32e-05	0.00149	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	4.32e-05	0.00149	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.28e-05	0.00148	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.25e-05	0.00147	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.19e-05	0.00145	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	4.13e-05	0.00143	CbGpPWpGaD
Oxcarbazepine—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.99e-05	0.00138	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.92e-05	0.00136	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.85e-05	0.00133	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.74e-05	0.00129	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.54e-05	0.00122	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.54e-05	0.00122	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.49e-05	0.00121	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	3.44e-05	0.00119	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.4e-05	0.00117	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	3.36e-05	0.00116	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.28e-05	0.00113	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.26e-05	0.00112	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.21e-05	0.00111	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.2e-05	0.00111	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	3.19e-05	0.0011	CbGpPWpGaD
Oxcarbazepine—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.17e-05	0.00109	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.09e-05	0.00107	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.05e-05	0.00105	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.05e-05	0.00105	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.00105	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	3.03e-05	0.00105	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.02e-05	0.00104	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.96e-05	0.00102	CbGpPWpGaD
Oxcarbazepine—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.96e-05	0.00102	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.94e-05	0.00102	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.8e-05	0.000968	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.76e-05	0.000952	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.75e-05	0.000949	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.73e-05	0.000945	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.71e-05	0.000937	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	2.66e-05	0.000919	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.62e-05	0.000904	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	2.48e-05	0.000858	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.47e-05	0.000855	CbGpPWpGaD
Oxcarbazepine—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.36e-05	0.000817	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.2e-05	0.000759	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	2.19e-05	0.000757	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	2.16e-05	0.000747	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	2.12e-05	0.000734	CbGpPWpGaD
Oxcarbazepine—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.11e-05	0.00073	CbGpPWpGaD
Oxcarbazepine—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.01e-05	0.000695	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.97e-05	0.000681	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.95e-05	0.000674	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.88e-05	0.00065	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.86e-05	0.000642	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.7e-05	0.000586	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.64e-05	0.000568	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.64e-05	0.000568	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.62e-05	0.00056	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.6e-05	0.000553	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.6e-05	0.000553	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.57e-05	0.000542	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.56e-05	0.00054	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.49e-05	0.000514	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.46e-05	0.000505	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.45e-05	0.000502	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	1.44e-05	0.000496	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.35e-05	0.000465	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.34e-05	0.000463	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	1.31e-05	0.000453	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.3e-05	0.00045	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.29e-05	0.000444	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.21e-05	0.000417	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.2e-05	0.000414	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.14e-05	0.000392	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.13e-05	0.00039	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.12e-05	0.000388	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.11e-05	0.000382	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.04e-05	0.000358	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.03e-05	0.000356	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.01e-05	0.000348	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.93e-06	0.000343	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.78e-06	0.000338	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.26e-06	0.00032	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.78e-06	0.000303	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.74e-06	0.000302	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	8.64e-06	0.000299	CbGpPWpGaD
Oxcarbazepine—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	8.53e-06	0.000295	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	7.88e-06	0.000272	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	7.72e-06	0.000267	CbGpPWpGaD
Oxcarbazepine—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	7.38e-06	0.000255	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.26e-06	0.000251	CbGpPWpGaD
Oxcarbazepine—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	6.36e-06	0.00022	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.06e-06	0.000209	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.97e-06	0.000206	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	5.97e-06	0.000206	CbGpPWpGaD
Oxcarbazepine—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	5.71e-06	0.000197	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.57e-06	0.000192	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.28e-06	0.000182	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	3.59e-06	0.000124	CbGpPWpGaD
Oxcarbazepine—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	3.43e-06	0.000119	CbGpPWpGaD
